Trustworthy, explainable AI to analyze, predict, and understand.

Abzu unlocks discoveries in data, revealing the insights that fuel innovation.

Proven team, technology, and results.

Abzu delivers groundbreaking results, bridging the gap between data and discoveries.

Abzu’s measurable impact.

Where proven results speak louder than promises, Abzu stands apart.

Dive into our curated collection of case studies that showcase how trustworthy and explainable AI can reshape the landscape of disease understanding and drug design.

Abzu’s QLattice uniquely identified key “partner” genes involved in skin spaceflight response, a new discovery for how spaceflight damages skin.
Understanding how bears can hibernate without developing blood clots or muscle atrophy can help humans prepare for the future of space travel.
A strategic partnership with Contera Pharma included ASO and siRNA therapeutic designs and target identification.

Abzu is your partner in understanding and design.

A cycle of innovation and optimization — to realization.

Whether we start with designs or your data, Abzu provides you the insights and confidence to accelerate your R&D and transform concepts into reality.

Abzu’s story and mission:

Ready to transcend insufficient analytics and black-box AI?

Abzu unlocks discoveries in data, revealing insights that fuel innovation. Our proprietary explainable AI, the QLattice® is the cornerstone of our approach.

Founded in 2018, Abzu has offices in Copenhagen and Barcelona.

“Abzu” is an Ancient Sumerian word meaning “subterranean water,” with an additional religious context of “the source of everything.”

The latest in pharma R&D research, perspective, and events.

Pioneering the path to in vivo success.

Here we use the QLattice® to generate siRNA activity models from publicly available data to create insights that can be used to design active siRNAs.

Artificial intelligence: Selective boom? We consider the benefits of explainable AI and its applications within the pharma industry.

RNA Leaders Europe is the #1 event focused on the development of mRNA, RNAi, ASOs, oligonucleotides, vaccines, microRNAs, genome editing, wider nucleic acids & RNA targets.

The QLattice®: Abzu’s proprietary explainable AI.

Experience the future of AI, where accuracy meets simplicity and explainability.

Models developed by the QLattice have unparalleled accuracy, even with very little data, and are uniquely simple to understand.

Research powered by Abzu’s technology.

From our in silico lab to the frontiers of science.

We proudly showcase the extensive range of research journals where our technology has been cited. Each is a testament to how our proprietary explainable AI reveals groundbreaking insights in science.

The QLattice is internationally recognized for explainability and performance.

We're pioneering a future where the decisions made by AI are as clear as they are powerful.

Only explainable AI reveals “the why” behind predictions. No prying, no forcing. Simply: Decisions you can understand.

ISO 27001 certified for trustworthy AI.

“Cool Vendor” for explainable AI.

Technology created and patented by Abzu.

Awarded multi-million EIC Accelerator grant.

Gartner® and Cool Vendors™ are registered trademarks and service marks, and the Gartner Cool Vendor badge is a trademark and service mark of Gartner, Inc. and/or its affiliates, and are used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Read the 2022 Gartner® Cool Vendors™ in AI Governance and Responsible AI — From Principles to Practice report.

Abzu is making headlines.

Abzu's innovative work in AI and pharma R&D makes waves in the scientific community and beyond.

February 7, 2024


Don’t settle for black box: Why only explainable AI is built for pharma.

June 12, 2023


AI in Pharma: Balancing Reality with Possibility.

May 5, 2023


20 Nordic startups to watch, according to investors.

May 9, 2022


Could Artificial Intelligence Provide the Key to Life Saving Medicines?

Subscribe for
notifications from Abzu.

You can opt out at any time. We’re cookieless, and our privacy policy is actually easy to read.